Match!

Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease

Published on Dec 18, 2018in Frontiers in Neurology2.635
· DOI :10.3389/fneur.2018.01081
Jens Burchard Schröder4
Estimated H-index: 4
,
Matthias Pawlowski7
Estimated H-index: 7
+ 5 AuthorsTobias Warnecke24
Estimated H-index: 24
Abstract
Background: Parkinson’s disease (PD) is a common neurodegenerative disorder. The contribution of the immune system to its pathogenesis remains incompletely understood. Methods: In this study, we performed comprehensive immune cell profiling in the cerebrospinal fluid (CSF) and peripheral blood (PB) of PD patients. Ten PD patients were diagnosed according to brain bank criteria and underwent detailed clinical examination, magnetic resonance imaging, PB and CSF immune cell profiling by multiparameter flow cytometry, and cytokine and chemokine measurements by bead-based arrays. Thirteen healthy elderly volunteers served as control population. Results: The proportions of activated T-lymphocytes and nonclassical monocytes in the CSF were increased in patients with PD compared to the control group. In accordance, we found increased levels of the pro-inflammatory cytokines IL-2, IL-6 and TNFα and of the monocyte chemoattractant protein 1 (MCP-1) in the CSF of the included PD patients. Conclusions: Our data provide novel evidence for a response of the innate and adaptive immune system in the central nervous system of patients with PD.
  • References (44)
  • Citations (4)
📖 Papers frequently viewed together
151 Citations
55 Citations
65 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References44
Newest
#1Sara Hall (Lund University)H-Index: 13
#2Shorena Janelidze (Lund University)H-Index: 22
Last. Oskar Hansson (Lund University)H-Index: 64
view all 6 authors...
Inflammation has been implicated in the pathogenesis of Parkinson’s disease (PD). We here investigate levels of inflammatory biomarkers in cerebrospinal fluid (CSF) in PD and atypical parkinsonian disorders (APD) compared with neurologically healthy controls. We included 131 patients with PD and 27 PD with dementia (PDD), 24 with multiple system atrophy (MSA), 14 with progressive supranuclear palsy (PSP) and 50 controls, all part of the Swedish BioFINDER study. CSF was analyzed for CRP, SAA, IL-...
15 CitationsSource
#1Matthias PawlowskiH-Index: 7
#2Gero LuegH-Index: 2
Last. Thomas DuningH-Index: 25
view all 9 authors...
Abstract Frontotemporal dementia (FTD) is a heterogeneous neurodegenerative disorder. The contribution of the immune system to its pathogenesis remains incompletely understood. In this study, we performed comprehensive immune cell profiling in the cerebrospinal fluid (CSF) and peripheral blood of patients with FTD. Thirty-two patients with behavioral variant frontotemporal dementia and 25 patients with primary progressive aphasia were included and compared to 14 healthy elderly controls. All pat...
1 CitationsSource
#1D.A Cook (Emory University)H-Index: 2
#2George T. Kannarkat (Emory University)H-Index: 8
Last. MariadeLourdes Tansey (Emory University)H-Index: 8
view all 11 authors...
Mutations associated with leucine-rich repeat kinase 2 are the most common known cause of Parkinson’s disease. The known expression of leucine-rich repeat kinase 2 in immune cells and its negative regulatory function of nuclear factor of activated T cells implicates leucine-rich repeat kinase 2 in the development of the inflammatory environment characteristic of Parkinson’s disease. The aim of this study was to determine the expression pattern of leucine-rich repeat kinase 2 in immune cell subse...
38 CitationsSource
#1R Lee Mosley (UNMC: University of Nebraska Medical Center)H-Index: 41
#2Howard Eliot Gendelman (UNMC: University of Nebraska Medical Center)H-Index: 89
7 CitationsSource
#1David Sulzer (Columbia University)H-Index: 64
#2Roy N. Alcalay (Columbia University)H-Index: 29
Last. Alessandro Sette (La Jolla Institute for Allergy and Immunology)H-Index: 129
view all 24 authors...
Epitopes derived from two regions of α-synuclein elicit immune responses in patients with Parkinson’s disease, involving IL-5-secreting CD4+ T cells, as well as IFNγ-secreting CD8+ cytotoxic T cells.
130 CitationsSource
#1Wassim Elyaman (Brigham and Women's Hospital)H-Index: 30
#2Samia J. Khoury (AUB: American University of Beirut)H-Index: 69
Interleukin (IL)-9 producing CD4+ T helper cells (Th9) are the newest addition to the T helper cell subsets. IL-9 binds to a heterodimeric receptor consisting of the IL-9 receptor (IL-9R) and a common γ chain also presents in IL-2, IL-4, IL-7, and IL-15 receptor complexes. In addition to Th9 cells, Th17 cells secrete smaller amounts of IL-9. Many functional and regulatory roles associated with Th9 cells are currently not fully understood. IL-9 is a pleiotropic cytokine that affects the activity ...
21 CitationsSource
Microglial activation is a key aspect of the neuroinflammatory process in neurodegenerative disorders including idiopathic and atypical parkinsonian disorders. With positron emission tomography (PET) it has become possible to image this phenomenon in vivo and over the last years patterns of microglia activation corresponding with the known distribution of neuropathological changes in these disorders have been demonstrated using this technique. In addition the effects of interventions aimed at su...
19 CitationsSource
#1Lisa Zondler (University of Ulm)H-Index: 8
#2Kathrin Muller (University of Ulm)H-Index: 14
Last. Jochen H. Weishaupt (University of Ulm)H-Index: 27
view all 22 authors...
Amyotrophic lateral sclerosis (ALS) is a devastating progressive neurodegenerative disease affecting primarily the upper and lower motor neurons. A common feature of all ALS cases is a well-characterized neuroinflammatory reaction within the central nervous system (CNS). However, much less is known about the role of the peripheral immune system and its interplay with CNS resident immune cells in motor neuron degeneration. Here, we characterized peripheral monocytes in both temporal and spatial d...
35 CitationsSource
#1Ronald B. Postuma (MGH: Montreal General Hospital)H-Index: 53
#2Daniela Berg (German Center for Neurodegenerative Diseases)H-Index: 35
Last. Günther Deuschl (CAU: University of Kiel)H-Index: 32
view all 18 authors...
This document presents the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's disease (PD). The Movement Disorder Society PD Criteria are intended for use in clinical research but also may be used to guide clinical diagnosis. The benchmark for these criteria is expert clinical diagnosis; the criteria aim to systematize the diagnostic process, to make it reproducible across centers and applicable by clinicians with less expertise in PD diagnosis. Although motor abnormalities r...
726 CitationsSource
#1Brian Kevin Stansfield (Georgia Regents University)H-Index: 8
#2David A. Ingram (IU: Indiana University)H-Index: 24
Monocytes are primitive hematopoietic cells that primarily arise from the bone marrow, circulate in the peripheral blood and give rise to differentiated macrophages. Over the past two decades, considerable attention to monocyte diversity and macrophage polarization has provided contextual clues into the role of myelomonocytic derivatives in human disease. Until recently, human monocytes were subdivided based on expression of the surface marker CD16. “Classical” monocytes express surface markers ...
60 CitationsSource
Cited By4
Newest
#1Zulvikar Syambani Ulhaq (UM: State University of Malang)
#2Cristian Peinado Garcia (Weston General Hospital)H-Index: 1
Strong evidence supports the involvement of inflammation processes in the development and progression of Parkinson’s disease (PD), where increasingly correlations have been identified between genetic variations in inflammation-related genes and PD. However, data varies between studies. Therefore, we conducted a meta-analysis to clarify associations between inflammation-related gene polymorphisms and PD risk. All studies were identified through online databases. Pooled and stratified groups based...
1 CitationsSource
#1Eng-King Tan (NUS: National University of Singapore)H-Index: 54
#2Yin Xia Chao (NUS: National University of Singapore)H-Index: 8
Last. Joseph Jankovic (BCM: Baylor College of Medicine)H-Index: 132
view all 6 authors...
Multiple lines of evidence indicate that immune system dysfunction has a role in Parkinson disease (PD); this evidence includes clinical and genetic associations between autoimmune disease and PD, impaired cellular and humoral immune responses in PD, imaging evidence of inflammatory cell activation and evidence of immune dysregulation in experimental models of PD. However, the mechanisms that link the immune system with PD remain unclear, and the temporal relationships of innate and adaptive imm...
2 CitationsSource
#1Efthalia Angelopoulou (UoA: National and Kapodistrian University of Athens)H-Index: 3
#2Yam Nath Paudel (Monash University Malaysia Campus)H-Index: 3
Last. Christina Piperi (UoA: National and Kapodistrian University of Athens)H-Index: 31
view all 5 authors...
Parkinson’s disease (PD) is the most common neurodegenerative movement disorder without any objective biomarker available to date. Increasing evidence highlights the critical role of neuroinflammation, including T cell responses, and spreading of aggregated α-synuclein in PD progression. Lymphocyte-activation gene 3 (LAG3) belongs to the immunoglobulin (Ig) superfamily expressed by peripheral immune cells, microglia and neurons and plays a key role in T cell regulation. The role of LAG3 has been...
Source
#1José Fidel Baizabal-Carvallo (Universidad de Guanajuato)H-Index: 13
Last. Marlene Alonso-JuarezH-Index: 7
view all 2 authors...
Abstract Parkinsons disease (PD) is the second most common neurodegenerative disorder. Despite its high frequency the etiology is still unclear; several lines of evidence show that an inflammatory process is implicated in the pathogenesis of this disorder; where activation of brain microglia plays a central role in the damage of dopaminergic neurons of the substantia nigra. Such inflammation has been attributed to the toxic effect of aggregated α-synuclein; however, evidence also implicates an a...
2 CitationsSource
#1Jincheol Seo (KNU: Kyungpook National University)H-Index: 1
#2Junghyung Park (Korea Research Institute of Bioscience and Biotechnology)H-Index: 1
Last. Philyong KangH-Index: 4
view all 22 authors...
Abstract Study of interactions between the nervous system and immunity offers insights into the pathogenesis of Parkinson’s disease (PD) and potential therapeutic strategies for neurodegenerative diseases. Studies on rodents have revealed regulatory mechanisms of microglial activation and T lymphocyte recruitment in PD. However, the mechanisms underlying chronic T lymphocyte infiltration into the brain after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) injection into a non-human primate (...
2 CitationsSource
#1Federico Paolini Paoletti (University of Perugia)H-Index: 2
#2Lorenzo Gaetani (University of Perugia)H-Index: 6
Last. Lucilla Parnetti (University of Perugia)H-Index: 50
view all 3 authors...
Abstract An accurate and early diagnosis of degenerative parkinsonian syndromes is a major need for their correct and timely therapeutic management. The current diagnostic criteria are mostly based on clinical features and molecular imaging. However, diagnostic doubts often persist especially in the early stages of diseases when signs are slight, ambiguous and overlapping among different syndromes. Molecular imaging may not be altered in the early stages of diseases, also failing to discriminate...
Source
#2Lorenzo GaetaniH-Index: 6
Last. Lucilla ParnettiH-Index: 50
view all 3 authors...
The development of disease modifying strategies in Parkinson’s disease (PD) largely depends on the ability to identify suitable populations after accurate diagnostic work-up. Therefore, patient molecular profiling and disease subtyping are mandatory. Thus far, in clinical trials, PD has been considered to be a “single entity”. Conversely, in front of the common feature of nigro-striatal degeneration, PD is pathogenically heterogeneous with a series of several biological and molecular pathways th...
Source
#1Anna PiccaH-Index: 14
#2Flora GuerraH-Index: 12
Last. Anna Rita BentivoglioH-Index: 47
view all 13 authors...
Systemic inflammation and mitochondrial dysfunction are involved in neurodegeneration in Parkinson’s disease (PD). Extracellular vesicle (EV) trafficking may link inflammation and mitochondrial dysfunction. In the present study, circulating small EVs (sEVs) from 16 older adults with PD and 12 non-PD controls were purified and characterized. A panel of serum inflammatory biomolecules was measured by multiplex immunoassay. Protein levels of three tetraspanins (CD9, CD63, and CD81) and selected mit...
6 CitationsSource
#1Ruwani Wijeyekoon (University of Cambridge)H-Index: 5
#2Deborah Kronenberg-Versteeg (University of Cambridge)H-Index: 2
Last. Menna R. Clatworthy (University of Cambridge)H-Index: 30
view all 13 authors...
Abstract The innate immune system is implicated in Parkinson’s disease (PD), but peripheral in-vivo clinical evidence of the components and driving mechanisms involved and their relationship with clinical heterogeneity and progression to dementia remain poorly explored. We examined changes in peripheral innate immune-related markers in PD cases (n=41) stratified according to risk of developing early dementia. ‘Higher Risk’(HR) (n=23) and ‘Lower Risk’ (LR) (n=18) groups were defined according to ...
Source
#1Joseph J. Sabatino (UCSF: University of California, San Francisco)H-Index: 6
#2Anne-Katrin Pröbstel (University of Basel)H-Index: 10
Last. Scott S. Zamvil (UCSF: University of California, San Francisco)H-Index: 52
view all 3 authors...
B cells are essential components of the adaptive immune system and have important roles in the pathogenesis of several central nervous system (CNS) diseases. Besides producing antibodies, B cells perform other functions, including antigen presentation to T cells, production of proinflammatory cytokines and secretion of anti-inflammatory cytokines that limit immune responses. B cells can contribute to CNS disease either through their actions in the periphery (meaning that they have an ‘outside-in...
1 CitationsSource